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In the present work, small interference RNA was used to
knock-down acyl-CoA binding protein (ACBP) in HeLa, HepG2
and Chang cells. Transfection with ACBP-specific siRNA
stopped growth, detached cells from the growth surface and
blocked thymidine and acetate incorporation. The results show
INTRODUCTION
Living cells encounter a number of problems in handling
hydrophobic metabolites such as fatty acids, fatty acid derivatives
and phospholipids. Such molecules are poorly soluble, partition
into biomembranes and bind unspecifically to cellular proteins
and enzymes, having adverse effects on their activities. Despite
this, it is well recognized that these biomolecules also have
important signalling properties. Fatty acyl-CoA esters, which are
both important intermediates in lipid metabolism and signal
molecules [1], are strong detergents, suggesting that their
intracellular concentration must be tightly controlled.
The majority of the cellular long-chain acyl-CoA esters are
presumed to be sequestered with acyl-CoA binding protein
(ACBP) in io (reviewed in [1]). Intracellular ACBPs are
members of a multigene family (reviewed in [2]). The basal
isoform is highly conserved and is found in all eukaryotic species
examined, ranging from yeast and plants, to reptiles, birds and
mammals [3]. ACBP binds long-chain acyl-CoA esters speci-
fically, with an affinity of approximately 1 nM [4–6]. Its ability to
mediate intermembrane acyl-CoA transport in itro [7], to protect
acyl-CoA esters from acyl-CoA hydrolases [8], to protect acetyl-
CoA carboxylase from the inhibitory effects of acyl-CoA esters
[8] and to create an intracellular acyl-CoA pool [9,10] indicate
that ACBP is involved in intracellular handling of acyl-CoA
esters. Regardless of the known in itro functions, only limited
information has been obtained about the function of ACBP in
io. ACBP expression is significantly up-regulated during adipo-
cyte differentiation, and expression of high levels of ACBP
antisense RNA in 3T3-L1 pre-adipocytes decreased endogenous
ACBP levels and accumulation of triacylglycerols [11].
Depletion of Acb1p (the yeast homologue of ACBP) in
Saccharomyces cereisiae results in severe pertubations in
membrane assembly, organization and organelle structures [12],
suggesting that it may be involved in vesicular trafficking and in
the maintenance of the integrity of cellular compartments.
Recently, it was reported that targeted disruption of ACBP in
Trypanosoma brucei results in lethality [13], suggesting that
ACBP plays an essential role in this organism. In the present
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polymerase ; siRNA, small interference RNA.
1 To whom correspondence should be addressed (e-mail nils.f!bmb.sdu.dk).
that depletion of ACBP in mammalian cells results in lethality,
suggesting that ACBP is an essential protein.
Key words: ACBP, acyl-CoA esters, lipid metabolism, small
interference RNA (siRNA).
work, we show for the first time that knock-down of ACBP in
human cell lines by small interference RNA (siRNA) results
in metabolically inactive and non-viable cells, strongly im-
plying that ACBP plays a pivotal role in human cells.
EXPERIMENTAL
Cell cultures, siRNA preparation and transfection
HeLa, HepG2 and Chang cells were grown in Dulbecco’s
modified Eagle’s medium supplemented with 10% (v}v) fetal
calf serum and penicillin and streptomycin. Cells were regularly
passaged to maintain exponential growth, but did not exceed
6 passages. Prior to transfection (24 h), cells were trypsinized,
diluted in fresh media without antibiotics and transferred to
six-well plates. On the day of transfection, cells were at 50–70%
confluency. Transfections of siRNA were carried out using
oligoFECTAMINETM according to the manufacturer’s instruc-
tions (Invitrogen, Groningen, The Netherlands). Target-specific
siRNA duplexes were designed as described previously [14] and
purchased from Dharmacon Research (Lafayette, CO, U.S.A.).
The human ACBP (NCBI accession no. M15887)-specific siRNA
was positioned at 199–219 relative to the start codon and was
compared with sequences in the human EST (expressed sequence
tag) database to confirm that no other genes were targeted. A
sequence targeting the Photinus pyralis firefly luciferase gene
(NCBI accession no. X65324) over DNA bases 153–175 was used
as an unspecific siRNA control [15]. Unless otherwise stated, all
experiments were carried out at least three times.
Western blotting
For Western blotting, cells attached to the plate were scraped off
with a rubber policeman and combined with cells in the medium.
The entire population of cells were then harvested by centri-
fugation for 5 min at 800 g, washed in ice-cold PBS, solubilized
in SDS-sample buffer (150 ll) and denatured by heating to
95 °C for 5 min. Equal amounts of protein were separated on
10 or 15% (w}v) polyacrylamide gels and transferred on to a
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nitrocellulose membrane. Immunostaining with specific anti-
bodies and peroxidase-conjugated secondary antibodies (Promega)
was carried out using enhanced chemiluminescence, according to
the manufacturer’s instructions (Amersham Pharmacia Biotech,
Uppsala, Sweden).
Thymidine incorporation, acetate incorporation and DNA
fragmentation
Thymidine incorporation was determined as described previously
[16], using [methyl-$H]thymidine (Amersham Pharmacia Bio-
tech). Briefly, HeLa, HepG2 or Chang cells were transfected with
10 nM siRNA against either ACBP or firefly luciferase (LUC
GL2), and 16 h prior to analysis, 1 lCi of [$H]thymidine was
added to each well. The entire cell population was harvested 72 h
post-transfection and $H-thymidine-labelled DNA was extracted
and analysed by scintillation counting. DNA fragmentation was
examined using an apoptotic DNA ladder kit, according to the
manufacturer’s instructions (Roche, Mannheim, Germany).
Acetate incorporation was carried out by incubating transfected
HepG2 cells with [1-"%C]acetate (2 lCi}well) (Amersham Phar-
macia Biotech) for 4 h. Cells were harvested as described above
and washed twice with ice-cold PBS. Lipids were extracted as
described previously [17], and acetate incorporation was de-
termined by scintillation counting.
RESULTS
To assess the role of the basal form of ACBP in human cell lines,
we designed siRNA duplexes directed against ACBP (Figure
1A). In parallel with the target-specific siRNA duplex, we used
a non-specific duplex of firefly luciferase from P. pyralis (LUC
GL2) at the same final concentration as the specific siRNAs
tested. The ACBP-specific siRNA was used to search the human
EST database to confirm that the chosen sequence did not share
Figure 1 Design and use of siRNA duplexes
(A) The siRNA sequence targeting human ACBP (NMj020548) was from position 199 to 219
relative to the start codon. The siRNA sequence targeting firefly luciferase from P. pyralis has
been described previously [15]. The ACBP-specific siRNA was compared with sequences in the
human EST database to confirm that no other genes were targeted. (B) HeLa cells were grown
and transfected in six-well plates with siRNA duplexes (final concentration indicated along the
bottom) as described in the Experimental section. Cells, either floating in the medium or
attached to the bottom of the well, were harvested 72 h post-transfection and the silencing effect
of ACBP was analysed by Western blotting. Equal loading was evaluated by Western blotting
against b-actin. The final concentration of siRNA duplexes is indicated. The dash (–) indicates
untransfected cells, and 0 nM denotes the addition of buffer instead of siRNA to the culture.
any significant identity with any other known genes. When Hela
cells were transfected with increasing concentrations of siRNA
duplex directed against ACBP we observed that the level of
ACBP was significantly reduced, as detected by Western blotting
(Figure 1B). Transfection with increasing concentrations of the
LUC GL2 siRNA duplex did not lead to a decrease in the level
of ACBP. The amount of loaded protein was equal, as judged
from the level of b-actin. These observations show that we are
able to reduce the level of ACBP in HeLa cells by RNA
interference in a specific manner.
Depletion of Acb1p in S. cereisiae results in severe pertu-
bations in membrane assembly, organization and organelle
structures [12], and targeted disruption of ACBP in T. brucei
results in lethality [13], suggesting that ACBP plays an essential
role in this organism. Consistent with these reports, we observed
severe alterations in cell morphology upon ACBP silencing
(Figure 2A). Targeted knock-down of ACBP resulted in ob-
servable growth arrest and detachment of cells from the growth
surface, resulting in cells floating in the media (Figure 2A). At the
lowest concentration of siRNA ACBP, a few cells that were still
attached to the growth surface could be observed; however, as
the concentration of siRNA ACBP was increased, only a minute
fraction of attached cells were observed. The detached cells were
stained blue when Trypan Blue was added directly to the well, a
strong indication of cell death (Figure 2B). In a similar fashion,
silencing of ACBP in HepG2 and Chang cells also resulted in
growth arrest and in detached cells with severe changes in their
morphology (Figure 2C).
That the cells are metabolically inactive is further supported
by the observation that ACBP-silenced cells are unable to
incorporate thymidine into cellular DNA. ACBP-silenced cells
only incorporated approx. 5% of the added thymidine into
DNA compared with LUC 2GL control-transfected HeLa and
HepG2 cells (Table 1), while approx. 15% was incorporated
into ACBP-silenced Chang cells. These data strongly imply that
ACBP-silenced cells are unable to divide. That ACBP-silenced
cells are metabolically inactive is further supported by the
observation that acetate incorporation is reduced to 12% of
control transfected cells (Table 1).
In an effort to determine how cell death occurs in ACBP-
silenced cells, we looked at parameters typically associated with
either apoptotic cells or necrotic cells. Fragmentation of DNA is
a typical measure of cells undergoing apoptosis. When DNA was
extracted from HeLa cells transfected with LUC GL2, control
siRNA or ACBP siRNA, and analysed by agarose electro-
phoresis, we did not observe fragmentation of the DNA as in
U937 apoptotic control cells (Figure 3). The DNA extracted
from ACBP-silenced cells only appeared mildly smeared and
showed no fragmentation, which implied that the cells were
necrotic and not apoptotic. Analysis of DNA at 24 and 48 h
post-transfection showed no sign of fragmentation (results not
shown). As DNA fragmentation is a marker for late apoptosis,
we hypothesized that early apoptosis could be induced prior to
cell death. In order to address this question we examined whether
activation of caspases occured in ACBP-silenced cells. Certain
caspases, e.g. caspase 3 and 7, are activated during early stages
of apoptosis, and are found to cleave the 113 kDa poly(ADP-
ribose) polymerase (PARP) to fragments of 89 and 24 kDa.
Detection of the 89 kDa PARP fragment by Western blotting
thus serves as an early marker of apoptosis. Interestingly, ACBP
silencing resulted in activation of caspases, as the majority of the
detectable PARP corresponded to a mobility of 89 kDa. Thus
these results indicate that ACBP silencing in HeLa cells results in
induction of early apoptosis, but prior to induction of late
apoptosis, cell death emerges.
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Figure 2 Silencing of ACBP results in profound changes in cell morphology and non-viable cells
(A) Phase-contrast microscopy of HeLa cells transfected with siRNA against ACBP (upper panel) or firefly luciferase (LUC GL2 ; lower panel). The final concentration of siRNA duplexes is indicated.
(B) Microscopic image of Trypan Blue-stained HeLa cells after transfection with 10 nM siRNA against either ACBP or firefly luciferase (LUC GL2). Trypan Blue was added directly to wells containing
transfected cells and analysed by optical microscopy. The arrow marks Trypan Blue-stained cells. (C) Phase microscopy of HepG2 cells (upper panel) and Chang cells (lower panel) transfected
with siRNA against firefly luciferase (LUC GL2) or ACBP. Cells were harvested and the level of ACBP and b-actin was determined by Western blotting. The final concentration of siRNA duplexes
is indicated. Controls (–) received buffer instead of siRNA.
Table 1 [3H]Thymidine and [14C]acetate incorporation into ACBP-silenced
cells
Mean‡standard error of the mean of two independent experiments is shown.
Radioactivity incorporated/well (d.p.m.)
siRNA LUC GL2 siRNA ACBP
[3H]Thymidine
HeLa 79377.8‡10041.3 3613.2‡345.7
HepG2 520603‡3687.6 26553.8‡4716.7
Chang 216174‡1697.8 31520.3‡104.3
[14C]Acetate
HepG2 12376.0‡329.3 1519.7‡92.3
DISCUSSION
The fact that ACBP is highly conserved in all eukaryotes from
yeast to man and plants to reptiles, and that it is ubiquitously
expressed, suggests that ACBP serves a basic function in all cells.
In the present study we have been able to reduce the level of
ACBP in HeLa, HepG2 and Chang cells by siRNA, and show
for the first time that ACBP silencing leads to growth arrest and
cell death, strongly suggesting that ACBP plays an essential role
in the human cell lines studied. These observations are highly
consistent with the fact that targeted disruption of ACBP in
T. brucei results in lethality [13]. Depletion of Acb1p in S. cereisiae
leads to a significant retardation of growth, which can be
complemented by ectopic expression of both mouse and human
ACBP (N. J. Færgeman and J. Knudsen, unpublished work)
indicating that ACBP is functionally identical in yeast and man,
Figure 3 Determination of early and late apoptosis events
Upper panel : HeLa cells were transfected with 10 nM siRNA against either firefly luciferase
(LUC GL2, lane 2) or ACBP (lane 3), and analysed by Western blotting 72 h post-transfection for
PARP cleavage, a measure for caspase activation during early apoptosis. Control transfection
(lane 1) received buffer instead of siRNA. Lower panel : late apoptosis was determined by DNA
fragmentation. DNA was extracted 72 h post-transfection and analysed by agarose electro-
phoresis. Lane 1, 1 kb DNA ladder ; lane 2, fragmented DNA from apoptotic U937 cells
provided in the kit ; lane 3, control transfected HeLa cells ; lane 4, cells transfected with
10 nM siRNA targeted against firefly luciferase (LUC GL2) ; and lane 5, cells transfected
with 10 nM siRNA targeted against ACBP.
making yeast a potential model system for studying the molecular
mechanism underlying the function of ACBP.
Depletion of Acb1p in yeast does not affect the acyl-CoA pool
size, but changes the acyl-CoA pool composition dramatically by
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increasing stearoyl-CoA approx. 5-fold [12]. This observation
suggests that Acb1p does not control the overall acyl-CoA level,
but rather is required for creating a specific pool of acyl-CoA
esters. This view is supported by the observation that the overall
phospholipid composition and turnover is unaffected by Acb1p
depletion, indicating that general glycerolipid synthesis does
not depend on Acb1p. However, depletion of Acb1p in yeast leads
to profound alterations in the morphology of subcellular organ-
elles and to the accumulation of a large number of vesicles and
aberrant membrane structures in the cytosol [12], indicating that
the Acb1p-bound acyl-CoA pool is required for membrane
trafficking. MS analysis of phospholipids extracted from isolated
plasma membranes revealed an increased level of sphingolipids
and lysophospholipids in Acb1p-depleted cells compared with
wild-type cells [12], supporting the notion that ACBP plays a
specific and pivotal role in intracellular trafficking of acyl-CoA
esters required for membrane remodelling or synthesis of specific
lipids required for vesicular trafficking and membrane turnover.
It has been suggested that the intracellular concentration of
unbound acyl-CoA esters is tightly controlled by the presence
of specific ACBP and acyl-CoA thioesterases [1]. In such a cellular
environment, transport by diffusion of unbound acyl-CoA esters
is very unlikely, and suggests that supply of substrates to acyl-
CoA-consuming enzymes depends on direct transfer from
acyl-CoA synthetases, or relies on ACBPs or carrier proteins.
Thus the fact that S. cereisiae, in contrast with mammalian cells,
does not express a cytosolic acyl-CoA hydrolase may explain
why yeast, but not human, cell lines are viable in the absence of
ACBP.
Acyl-CoA esters have also been shown to have regulatory
properties that are similar to those of other celluar components,
e.g. protein kinases, ion channels and transcription factors
(reviewed in [1,18]). Hence, depletion of the ACBP could have
multiple detrimental effects on essential cellular signal pathways.
Thus it is conceivable that cellular depletion of ACBP leads to
pertubation of cellular acyl-CoA trafficking, resulting in ham-
pering of essential pathways or functions in which long-chain
acyl-CoA esters participate [18]. This may also explain the
inability of pre-adipocytes to differentiate upon expression of
ACBP antisense [11]. Although it would have been interesting to
know how ACBP silencing affects the acyl-CoA level, we believe
that attempts to measure the acyl-CoA level in the present study
would be meaningless, since ATP depletion and cell death in
itself would deplete cells of acyl-CoA esters [19]. Cell death may
also explain why ACBP-silenced cells cannot complete the
apoptotic program.
The present work also shows that ACBPs carry out specific
functions in the cell that cannot be replaced by any of the
proteins which harbour an intrinsic ACBP domain. Besides
the basal ACBP, four other ABCP gene products have been identi-
fied within the human genome, containing 281, 358, 407 and 527
amino acids respectively [2]. In addition to the ACBP domain,
the 281-amino-acid and the 358-amino-acid protein contain two
ankyrin repeats and a D$,D#-enoyl-CoA isomerase domain re-
spectively. The observation that depletion of ACBP in human
cell lines is lethal makes these cell lines unsuitable for studying
ACBP function in io. However, S. cereisiae only expresses one
basal ACBP isoform, the function of which can be complemented
by human or mouse ACBP (see above). Thus yeast may therefore
be an excellent model system to study the in io function of
ACBP.
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